The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike subcutaneous injections, this technique offers a more convenient way to provide https://gerardwlnn827538.bloggazzo.com/39715809/glp-1-patches-a-novel-approach-to-blood-sugar-treatment